Home
Bliss Gvs Pharma Ltd PE Ratio

Bliss GVS Pharma Ltd
NSE: BLISSGVS
PE
Key Highlights
- The P/E Ratio of Bliss GVS Pharma Ltd is 16.3 as of 26 Mar 11:37 AM .
- The P/E Ratio of Bliss GVS Pharma Ltd changed from 10.7 on March 2020 to 15.6 on March 2024 . This represents a CAGR of 7.83% over 5 years.
- The Latest Trading Price of Bliss GVS Pharma Ltd is ₹ 122.1 as of 26 Mar 11:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.1 in 2024.
Historical P/E Ratio of Bliss GVS Pharma Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Bliss GVS Pharma Ltd
Company Fundamentals for Bliss GVS Pharma Ltd

Bliss GVS Pharma Ltd
NSE: BLISSGVS
Share Price
Market Price of Bliss GVS Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
25 Mar 2025 | 124.2 |
24 Mar 2025 | 122.85 |
21 Mar 2025 | 122.8 |
20 Mar 2025 | 120.85 |
19 Mar 2025 | 119.9 |
18 Mar 2025 | 117.6 |
17 Mar 2025 | 112.5 |
13 Mar 2025 | 114.55 |
12 Mar 2025 | 116.45 |
11 Mar 2025 | 118.2 |
SWOT Analysis Of Bliss GVS Pharma Ltd
BlinkX Score for Bliss GVS Pharma Ltd
Asset Value vs Market Value of Bliss GVS Pharma Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Bliss GVS Pharma Ltd | 1308 | 16.28 |
Sun Pharmaceutical Industries Ltd | 423723 | 35.9 |
Divis Laboratories Ltd | 154965 | 75.0 |
Cipla Ltd | 122002 | 24.5 |
Torrent Pharmaceuticals Ltd | 109393 | 58.8 |
Mankind Pharma Ltd | 98951 | 48.5 |
Company | |
---|---|
Bliss GVS Pharma Ltd | 1308 |
Sun Pharmaceutical Industries Ltd | 423723 |
Divis Laboratories Ltd | 154965 |
Cipla Ltd | 122002 |
Torrent Pharmaceuticals Ltd | 109393 |
Mankind Pharma Ltd | 98951 |
PE Ratio of Bliss GVS Pharma Ltd Explained
₹1308
Market cap
₹59
Earnings
16.3X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Bliss GVS Pharma Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Bliss GVS Pharma Ltd
Historical Revenue, EBITDA and Net Profit of Bliss GVS Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Bliss GVS Pharma Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Bliss GVS Pharma Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Bliss GVS Pharma Ltd
About Bliss GVS Pharma Ltd
- Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984.
- The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limited and further to Bliss GVS Pharma Limited on May 12, 2006. The Company, founded in 1984 with the objective of ensuring healthcare access worldwide, is one of the pharmaceutical industries' fastest-growing businesses.
- The Company has a robust portfolio of more than 250 products and is a global leader in the dosage forms for suppositories and pessaries.
- It has a strong foothold in Sub Saharan Africa.
- The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
Bliss GVS Pharma Ltd News Hub
Bliss GVS Pharma to table results
Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 October 2024. Po
Read more
18 Oct 24
Bliss GVS Pharma consolidated net profit declines 42.66% in the September 2024 quarter
Net profit of Bliss GVS Pharma declined 42.66% to Rs 24.26 crore in the quarter ended September 2024
Read more
25 Oct 24
Bliss GVS Pharma allots 1.57 lakh equity shares under ESOP
Bliss GVS Pharma has allotted 157,550 equity shares under ESOP on 04 October 2024. With this allotme
Read more
04 Oct 24
Bliss GVS Pharma schedules board meeting
Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 28 January 2025. Po
Read more
22 Jan 25